Cardiac Imaging: Page 189

Framingham risk doesn't predict plaque burden
By Eric Barnes
Risk factor schemes such as the Framingham risk assessment work fine for patient populations, but they do a poor job of predicting the atherosclerotic plaque burden of individuals, according to a new study by Dr. David Dowe and colleagues in the January American Journal of Roentgenology.
January 4, 2009
Merit adds to product line
By AuntMinnie.com staff writers
Disposable products developer Merit Medical Systems has added two new devices to its product line and received clearance from the U.S. Food and Drug Administration for its contrast management system.
December 29, 2008
Multislice CT beats aortography for pediatric thoracic aortic coarctation
By Caitanya Min
Results from a study by Tunisian researchers indicate that compared with invasive contrast aortography, 64-slice CT is the imaging modality of choice for pediatric patients with thoracic aortic coarctation.
December 24, 2008
Sleep cuts coronary artery calcification
By Eric Barnes
It is sleep, wrote William Shakespeare, that "knits up the ravelled sleave of care." But maybe just as important, a new study shows that getting enough sleep prevents coronary artery calcifications, which are strongly associated with morbidity and mortality.
December 22, 2008
Molecular Insight completes phase II trial for Zemiva
By AuntMinnie.com staff writers
Radiopharmaceutical developer Molecular Insight Pharmaceuticals has completed a phase II clinical trial for its chest imaging agent Zemiva.
December 22, 2008
Epix gets FDA OK for Vasovist
By AuntMinnie.com staff writers
MRI contrast developer Epix Pharmaceuticals has received approval from the U.S. Food and Drug Administration to market its blood pool MR angiography contrast agent.
December 22, 2008
CT installed base triples in cardiology practices
By Rick Dana Barlow
Cardiologists across the U.S. have been so enthralled with CT that they've tripled the modality's installed base of units within cardiology practices in the past two years, according to a new report scheduled by market research firm IMV Medical Information Division.
December 22, 2008
2008 12 22 14 19 54 33 2008 12 23 Ct Units
Late MRI enhancement predicts death risk in hypertrophic cardiomyopathy
By Charlene Laino
In patients with hypertrophic cardiomyopathy, myocardial late gadolinium enhancement on contrast-enhanced MRI may be a risk factor for cardiac death, preliminary research from the Mayo Clinic in Rochester, MN, suggests.
December 17, 2008
Lantheus touts positive Definity results
By AuntMinnie.com staff writers
Lantheus Medical Imaging said that a new study in the American Journal of Cardiology found a survival benefit among hospitalized patients undergoing echocardiography procedures enhanced by its Definity contrast agent.
December 15, 2008
Siemens gets FDA OK for IQ-SPECT
By AuntMinnie.com staff writers
Siemens Healthcare has received clearance from the U.S. Food and Drug Administration for IQ-SPECT.
December 14, 2008
Nuclear myocardial perfusion imaging: Vulnerable to self-referral?
By Kate Madden Yee
Nuclear myocardial perfusion imaging (MPI) can be a powerful tool against heart disease, but the procedure is costly. Researchers are investigating how MPI is used -- and by whom -- to evaluate whether overuse of the technology contributes to inflated healthcare costs.
December 14, 2008
2008 12 10 15 41 48 11 Slide8 Ic Insider
FDA panel rejects Acusphere contrast agent
By AuntMinnie.com staff writers
A U.S. Food and Drug Administration panel rejected the regulatory application for the Imagify ultrasound contrast agent from Acusphere of Watertown, MA.
December 10, 2008
Previous Page
Page 189 of 325
Next Page